Cargando…
Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926954/ https://www.ncbi.nlm.nih.gov/pubmed/36251752 http://dx.doi.org/10.1002/cac2.12369 |
| _version_ | 1784888381158719488 |
|---|---|
| author | Liu, Rui Liu, Panpan Bi, Huichang Ling, Jianhua Zhang, Huiqin Zhang, Mingquan Hu, Yumin Chiao, Paul J Huang, Peng Liu, Jinyun |
| author_facet | Liu, Rui Liu, Panpan Bi, Huichang Ling, Jianhua Zhang, Huiqin Zhang, Mingquan Hu, Yumin Chiao, Paul J Huang, Peng Liu, Jinyun |
| author_sort | Liu, Rui |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9926954 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99269542023-02-16 Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization Liu, Rui Liu, Panpan Bi, Huichang Ling, Jianhua Zhang, Huiqin Zhang, Mingquan Hu, Yumin Chiao, Paul J Huang, Peng Liu, Jinyun Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-10-17 /pmc/articles/PMC9926954/ /pubmed/36251752 http://dx.doi.org/10.1002/cac2.12369 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Liu, Rui Liu, Panpan Bi, Huichang Ling, Jianhua Zhang, Huiqin Zhang, Mingquan Hu, Yumin Chiao, Paul J Huang, Peng Liu, Jinyun Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization |
| title | Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization |
| title_full | Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization |
| title_fullStr | Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization |
| title_full_unstemmed | Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization |
| title_short | Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization |
| title_sort | malignant transformation by oncogenic k‐ras requires idh2‐mediated reductive carboxylation to promote glutamine utilization |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926954/ https://www.ncbi.nlm.nih.gov/pubmed/36251752 http://dx.doi.org/10.1002/cac2.12369 |
| work_keys_str_mv | AT liurui malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization AT liupanpan malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization AT bihuichang malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization AT lingjianhua malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization AT zhanghuiqin malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization AT zhangmingquan malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization AT huyumin malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization AT chiaopaulj malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization AT huangpeng malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization AT liujinyun malignanttransformationbyoncogenickrasrequiresidh2mediatedreductivecarboxylationtopromoteglutamineutilization |